The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Feb. 23, 2016
Filed:
Sep. 03, 1999
Alessandro Sette, La Jolla, CA (US);
John Sidney, San Diego, CA (US);
Scott Southwood, Santee, CA (US);
Brian D. Livingston, San Diego, CA (US);
Robert Chestnut, Cardiff-by-the-Sea, CA (US);
Denise Marie Baker, San Diego, CA (US);
Esteban Celis, Rochester, MN (US);
Ralph T. Kubo, Carlsbad, CA (US);
Howard M. Grey, La Jolla, CA (US);
Alessandro Sette, La Jolla, CA (US);
John Sidney, San Diego, CA (US);
Scott Southwood, Santee, CA (US);
Brian D. Livingston, San Diego, CA (US);
Robert Chestnut, Cardiff-by-the-Sea, CA (US);
Denise Marie Baker, San Diego, CA (US);
Esteban Celis, Rochester, MN (US);
Ralph T. Kubo, Carlsbad, CA (US);
Howard M. Grey, La Jolla, CA (US);
Epimmune Inc., San Diego, CA (US);
Abstract
This invention uses our knowledge of the mechanisms by which antigen is recognized by T cells to identify and prepareepitopes, and to develop epitope-based vaccines directed towards malaria. More specifically, this application communicates our discovery of pharmaceutical compositions and methods of use in the prevention and treatment of malaria. In particular, this application discloses isolated peptides comprising oligopeptides, for example the oligopeptide GVSENIFLK, or isolated peptides conjugated with T helper peptides that are used as antigens in epitope-based vaccines to prevent and/or treat malaria.